• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Maire (BIT:MAIRE) Stock Faces Execution Questions Despite Backlog And Margin Gains

    Simply Wall St·07/31/2026 18:32:42
    Listen to the news

    Maire went into this earnings print with a stock that has been sliding, down about 18% over the past three months, and trading close to a DCF reference of €13.13. The immediate question for you is whether the headline results justify that caution.

    The short answer is that profit quality is the story. Q2 basic earnings per share held near €0.21 while net income excluding extra items reached about €70.5m on revenue of roughly €1.9b. For a project driven engineering and construction group, that mix of earnings and top line scale is central to assessing today’s muted share price in light of the new figures.

    Is Maire trading at a genuine discount, or is it roughly fair value given the small gap between its P/E, peer multiples and that €13.13 DCF reference price? See how the stock screens on our valuation analysis for Maire.

    Q2 2026 Earnings Summary

    • Revenue (Q2 2026 vs. Q2 2025): €1,867.1m vs. €1,690.1m (up about 10.5%)
    • Net Income Excl. Extra Items (Q2 2026 vs. Q2 2025): €70.5m vs. €65.2m (up about 8.3%)
    • Basic EPS (Q2 2026 vs. Q2 2025): €0.212 vs. €0.199 (up about 6.7%)
    • Trailing Net Profit Margin (Last 12 Months vs. Prior Year): 3.7% vs. 3.5% (indicating modest margin expansion year over year)

    Prefer clean, visual charts over wading through dense earnings tables and reports? See Maire's full financial picture, including a clear view of its valuation, in our company report for Maire.

    BIT:MAIRE Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026
    BIT:MAIRE Trailing 12-Month Revenue & Expenses Breakdown as at Jul 2026

    Maire bull case leans on execution and mix shift

    Bulls argue Maire is turning a big, traditional EPC backlog into higher quality earnings as NextChem grows. The latest numbers give some support. Group revenues of €3.7b with EBITDA of €266.2m and a 7.2% margin show earnings holding up while order intake reaches €7.2b and a book to bill of 2x. That points to backlog growth rather than drawdown. Within this, STS and NextChem stand out. Revenue of €285.7m, EBITDA of €68m and a 23.8% margin suggest the higher margin, technology heavy businesses are gaining weight. The record €702.6m NextChem backlog and €556.9m of orders, helped by Ballestra, line up with the claim that technology and licensing can become a larger earnings driver.

    Bear case focuses on project risk and green scale

    The bear story centers on heavy EPC exposure, geopolitical risk and a still small green platform. The H1 print shows why that argument is not going away. Integrated E&C still carries €3.4b of revenue and €198.2m of EBITDA with a 5.8% margin, so the lower margin, project heavy engine remains dominant. Backlog of €15.6b in E&C and €16.3b at group level extends execution risk well into 2028 and beyond. Middle East disruption required rerouting hundreds of shipments, which underlines operational fragility even if management expects reimbursement. NextChem’s €702.6m backlog is growing but still modest versus total backlog. Recent acquisitions in detergents, fertilizers and metals recycling are promising, yet they only start to hit the P&L from Q3, so the evidence that green and circular earnings can offset EPC cyclicality is still limited.

    Compare Maire's backlog strength and NextChem margin profile with how the market is already pricing the stock after the recent earnings release. Then see whether analysts are leaning into the bull story or siding with the caution. See the consensus price target analysis for Maire

    Stay Ahead With Simply Wall St

    If Maire's earnings mix and backlog profile have caught your attention, register for free with Simply Wall St and add it to a Watchlist to track the share price against fair value and watch for a better entry point. After you own the stock, use the Portfolio Command Center to cut through market noise and focus on the key events and metrics that matter to your holdings. For a broader lens on sentiment and investment angles, tap into the Community and see how other investors are thinking about Maire and stocks like it. By surfacing potential catalysts and risks early, Simply Wall St helps you act with confidence and stay a step ahead of the market.

    Seeking Alternatives Beyond Maire?

    Fresh stock themes can start moving quickly, and some entry points may pass quietly before the broader market reacts. Review these focused ideas while they are still timely.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.